Phase II study of weekly irinotecan and cisplatin for refractory or recurtent non-small cell lung cancer

Bibliographic Information

Title
Phase II study of weekly irinotecan and cisplatin for refractory or recurtent non-small cell lung cancer
Author
Takiguchi. Y, et. al.

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000781984059912
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top